175 related articles for article (PubMed ID: 33295723)
1. Is serum iron responsive protein-2 level associated with pulmonary functions and frequent exacerbator phenotype in COPD?
Acet Öztürk NA; Görek Dilektaşlı A; Demirdöğen E; Coşkun F; Ursavaş A; Karadağ M; Kunt Uzaslan E
Tuberk Toraks; 2020 Sep; 68(3):252-259. PubMed ID: 33295723
[TBL] [Abstract][Full Text] [Related]
2. Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.
Hao W; Li M; Zhang Y; Zhang C; Wang P
Postgrad Med J; 2020 Jan; 96(1131):28-32. PubMed ID: 31375557
[TBL] [Abstract][Full Text] [Related]
3. Serum CCL-18 level is a risk factor for COPD exacerbations requiring hospitalization.
Dilektasli AG; Demirdogen Cetinoglu E; Uzaslan E; Budak F; Coskun F; Ursavas A; Ercan I; Ege E
Int J Chron Obstruct Pulmon Dis; 2017; 12():199-208. PubMed ID: 28115842
[TBL] [Abstract][Full Text] [Related]
4. The usefulness of soluble receptor for advanced glycation end-products in the identification of COPD frequent exacerbator phenotype.
Miłkowska-Dymanowska J; Białas AJ; Szewczyk K; Kurmanowska Z; Górski P; Piotrowski WJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3879-3884. PubMed ID: 30568439
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Airway Thickening and Serum Cytokines in COPD Patients with Frequent Exacerbations: A Heart of the Matter.
Lin Y; Sang L; Wang J; Chen Y; Lai J; Zhu X; Yang Y; Zhang Z; Liu Y; Wen S; Zhang N; Zhao D
Int J Chron Obstruct Pulmon Dis; 2023; 18():2353-2364. PubMed ID: 37928768
[TBL] [Abstract][Full Text] [Related]
6. Clinical and Functional Lung Parameters Associated With Frequent Exacerbator Phenotype in Subjects With Severe COPD.
Capozzolo A; Carratù P; Dragonieri S; Falcone VA; Quaranta VN; Liotino V; D'Alba G; Castellana G; Resta O
Respir Care; 2017 May; 62(5):572-578. PubMed ID: 28270543
[TBL] [Abstract][Full Text] [Related]
7. Serum Amyloid A in Stable COPD Patients is Associated with the Frequent Exacerbator Phenotype.
Zhao D; Abbasi A; Rossiter HB; Su X; Liu H; Pi Y; Sang L; Zhong W; Yang Q; Guo X; Zhou Y; Li T; Casaburi R; Zhang N
Int J Chron Obstruct Pulmon Dis; 2020; 15():2379-2388. PubMed ID: 33061355
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes of chronic obstructive pulmonary disease phenotypes. One center prospective study.
Said A; Esmail M; Abdel Naiem E; Zaki Z; Raouf R
Adv Respir Med; 2021; 89(4):369-377. PubMed ID: 34494240
[TBL] [Abstract][Full Text] [Related]
9. Characterization Associated with the Frequent Severe Exacerbator Phenotype in COPD Patients.
Wu YK; Su WL; Yang MC; Chen SY; Wu CW; Lan CC
Int J Chron Obstruct Pulmon Dis; 2021; 16():2475-2485. PubMed ID: 34511892
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
[TBL] [Abstract][Full Text] [Related]
11. The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review.
Wu JJ; Xu HR; Zhang YX; Li YX; Yu HY; Jiang LD; Wang CX; Han M
BMC Pulm Med; 2020 Apr; 20(1):103. PubMed ID: 32326924
[TBL] [Abstract][Full Text] [Related]
12. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
[TBL] [Abstract][Full Text] [Related]
13. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".
Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J
Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606
[TBL] [Abstract][Full Text] [Related]
14. Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS.
Zhang WZ; Oromendia C; Kikkers SA; Butler JJ; O'Beirne S; Kim K; O'Neal WK; Freeman CM; Christenson SA; Peters SP; Wells JM; Doerschuk C; Putcha N; Barjaktarevic I; Woodruff PG; Cooper CB; Bowler RP; Comellas AP; Criner GJ; Paine R; Hansel NN; Han MK; Crystal RG; Kaner RJ; Ballman KV; Curtis JL; Martinez FJ; Cloonan SM
Sci Rep; 2020 Jun; 10(1):10562. PubMed ID: 32601308
[TBL] [Abstract][Full Text] [Related]
15. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
16. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
Calle Rubio M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
[TBL] [Abstract][Full Text] [Related]
17. Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD.
Luo Y; Zhou L; Li Y; Guo S; Li X; Zheng J; Zhu Z; Chen Y; Huang Y; Chen R; Chen X
Respir Care; 2016 May; 61(5):680-8. PubMed ID: 26814217
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characterization and Treatment Patterns for the Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease with Severe or Very Severe Airflow Limitation.
Blasi F; Neri L; Centanni S; Falcone F; Di Maria G
COPD; 2017 Feb; 14(1):15-22. PubMed ID: 27824270
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease.
Wedzicha JA; Brill SE; Allinson JP; Donaldson GC
BMC Med; 2013 Aug; 11():181. PubMed ID: 23945277
[TBL] [Abstract][Full Text] [Related]
20. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
